136 related articles for article (PubMed ID: 27061518)
21. Management of early-stage cutaneous melanoma.
Aloia TA; Gershenwald JE
Curr Probl Surg; 2005 Jul; 42(7):460-534. PubMed ID: 16099230
[No Abstract] [Full Text] [Related]
22. Metastatic melanoma - a review of current and future treatment options.
Maverakis E; Cornelius LA; Bowen GM; Phan T; Patel FB; Fitzmaurice S; He Y; Burrall B; Duong C; Kloxin AM; Sultani H; Wilken R; Martinez SR; Patel F
Acta Derm Venereol; 2015 May; 95(5):516-24. PubMed ID: 25520039
[TBL] [Abstract][Full Text] [Related]
23. [New treatments for metastatic melanoma: a first hope].
Robert C; Mateus C
Rev Prat; 2011 Nov; 61(9 Suppl):S1-2. PubMed ID: 22338196
[No Abstract] [Full Text] [Related]
24. Combination immunotherapy breakthrough for melanoma.
Brower V
Lancet Oncol; 2015 Jul; 16(7):e318. PubMed ID: 26062775
[No Abstract] [Full Text] [Related]
25. Tumor mutational burden and response to programmed cell death protein 1 inhibitors in a case series of patients with metastatic desmoplastic melanoma.
Boussemart L; Johnson A; Schrock AB; Pal SK; Frampton GM; Fabrizio D; Chalmers Z; Lotem M; Gibney G; Russell J; Chmielowski B; Ross JS; Stephens PJ; Miller VA; Ali SM
J Am Acad Dermatol; 2019 Jun; 80(6):1780-1782. PubMed ID: 30576761
[No Abstract] [Full Text] [Related]
26. [Adjuvant drug therapy of malignant melanoma. Current knowledge and multi-center studies in German-speaking countries].
Hauschild A; Volkenandt M; Garbe C
Dtsch Med Wochenschr; 2000 Oct; 125(42):1272-8. PubMed ID: 11098240
[No Abstract] [Full Text] [Related]
27. Pilot study of high-dose, concurrent biochemotherapy for advanced melanoma.
Kim KB; Eton O; East MJ; Hodges C; Papadopoulos NE; Grimm EA; Bedikian AY
Cancer; 2004 Aug; 101(3):596-603. PubMed ID: 15274073
[TBL] [Abstract][Full Text] [Related]
28. Pembrolizumab (Keytruda) for metastatic melanoma.
Med Lett Drugs Ther; 2014 Nov; 56(1455):e114-5. PubMed ID: 25538981
[No Abstract] [Full Text] [Related]
29. Tamoxifen in the treatment of metastatic malignant melanoma.
Wagstaff J; Thatcher N; Rankin E; Crowther D
Cancer Treat Rep; 1982 Sep; 66(9):1771. PubMed ID: 7116353
[No Abstract] [Full Text] [Related]
30. The systemic treatment of advanced cutaneous melanoma.
Logan TF
Facial Plast Surg Clin North Am; 2003 Feb; 11(1):75-85. PubMed ID: 15062290
[No Abstract] [Full Text] [Related]
31. A clinicopathologic study of amelanotic melanoma.
Huvos AG; Shah JP; Goldsmith HS
Surg Gynecol Obstet; 1972 Dec; 135(6):917-20. PubMed ID: 5086000
[No Abstract] [Full Text] [Related]
32. Is there a role for targeting vascular endothelial growth factor/receptor axis in the treatment of patients with metastatic melanoma?
Kim KB
Cancer; 2013 Feb; 119(3):477-80. PubMed ID: 22915026
[No Abstract] [Full Text] [Related]
33. Chemotherapy and biologic therapies for melanoma: do they work?
Jilaveanu LB; Aziz SA; Kluger HM
Clin Dermatol; 2009; 27(6):614-25. PubMed ID: 19880049
[TBL] [Abstract][Full Text] [Related]
34. Use of sargramostim as maintenance therapy in patients with stage IV melanoma at high risk for systemic recurrence.
Hemrajani RH; Kim KB; Amos WR; Mann DE
Melanoma Res; 2007 Aug; 17(4):257-9. PubMed ID: 17625458
[No Abstract] [Full Text] [Related]
35. Intralesional therapy for in-transit and satellite metastases in melanoma.
Feeney KJ; Mastrangelo MJ
Surg Oncol Clin N Am; 2015 Apr; 24(2):299-308. PubMed ID: 25769713
[TBL] [Abstract][Full Text] [Related]
36. Malignant melanoma and its therapy: a review.
Chanda JJ; Callen JP; Stawiski MA
Cutis; 1979 Jun; 23(6):759-83. PubMed ID: 380931
[TBL] [Abstract][Full Text] [Related]
37. Pathologic complete response to intralesional interleukin-2 therapy associated with improved survival in melanoma patients with in-transit disease.
Hassan S; Petrella TM; Zhang T; Kamel-Reid S; Nordio F; Baccarelli A; Sade S; Naert K; Habeeb AA; Ghazarian D; Wright FC
Ann Surg Oncol; 2015; 22(6):1950-8. PubMed ID: 25366584
[TBL] [Abstract][Full Text] [Related]
38. [In vitro drug sensitivity profiling in melanoma].
Ugurel S
J Dtsch Dermatol Ges; 2008 Jul; 6(7):611. PubMed ID: 18611186
[No Abstract] [Full Text] [Related]
39. Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model.
Schmidt H; Bastholt L; Geertsen P; Christensen IJ; Larsen S; Gehl J; von der Maase H
Br J Cancer; 2005 Aug; 93(3):273-8. PubMed ID: 16052222
[TBL] [Abstract][Full Text] [Related]
40. GSK drug combination approved for advanced melanoma.
Inman S
Am J Manag Care; 2014 Feb; 20(2 Spec No.):E10. PubMed ID: 25764581
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
